Sumoylation, involving the non-covalent attachment of SUMO (Small Ubiquitin-like Modifier) proteins to target proteins, modifies amyloid beta (Aβ) production and tau protein function in AD (Li et al., 2003; Wilkinson and Henley, 2010). The gene discussed is MAPT; the disease is Alzheimer disease.